Coegin Pharma AB (NGM: COEGIN)

Coegin Pharma AB Statistics

Total Valuation

Coegin Pharma AB has a market cap or net worth of SEK 90.66 million. The enterprise value is 72.22 million.

Market Cap	90.66M
Enterprise Value	72.22M

Important Dates

The next estimated earnings date is Friday, November 22, 2024.

Earnings Date	Nov 22, 2024
Ex-Dividend Date	n/a

Share Statistics

Coegin Pharma AB has 15.96 million shares outstanding. The number of shares has increased by 33.30% in one year.

Shares Outstanding	15.96M
Shares Change (YoY)	+33.30%
Shares Change (QoQ)	+14.24%
Owned by Insiders (%)	2.23%
Owned by Institutions (%)	4.58%
Float	14.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	3.44
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.57
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.24

Current Ratio	4.24
Quick Ratio	4.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-78.02

Financial Efficiency

Return on equity (ROE) is -102.91% and return on invested capital (ROIC) is -63.27%.

Return on Equity (ROE)	-102.91%
Return on Assets (ROA)	-55.93%
Return on Capital (ROIC)	-63.27%
Revenue Per Employee	n/a
Profits Per Employee	-14.04M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.60%
50-Day Moving Average	6.94
200-Day Moving Average	4.88
Relative Strength Index (RSI)	28.85
Average Volume (20 Days)	21,833

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-17,000
Operating Income	-27.62M
Pretax Income	-28.08M
Net Income	-28.08M
EBITDA	-24.60M
EBIT	-27.62M
Earnings Per Share (EPS)	-2.89

Balance Sheet

Cash & Cash Equivalents	18.44M
Total Debt	n/a
Net Cash	18.44M
Net Cash Per Share	1.16
Equity (Book Value)	26.39M
Book Value Per Share	1.65
Working Capital	15.07M

Cash Flow

Operating Cash Flow	-20.63M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Coegin Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.30%
Shareholder Yield	-33.30%
Earnings Yield	-50.92%
FCF Yield	n/a

Stock Splits

The last stock split was on June 15, 2023. It was a reverse split with a ratio of 0.01.

Last Split Date	Jun 15, 2023
Split Type	Reverse
Split Ratio	0.01